Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Pancreatic Adenocarcinoma, Version 1.2019 JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Tempero, M. A., Malafa, M. P., Chiorean, E., Czito, B., Scaife, C., Narang, A. K., Fountzilas, C., Wolpin, B. M., Al-Hawary, M., Asbun, H., Behrman, S. W., Benson, A. B., Binder, E., Cardin, D. B., Cha, C., Chung, V., Dillhoff, M., Dotan, E., Ferrone, C. R., Fisher, G., Hardacre, J., Hawkins, W. G., Ko, A. H., LoConte, N., Lowy, A. M., Moravek, C., Nakakura, E. K., O'Reilly, E. M., Obando, J., Reddy, S., Thayer, S., Wolff, R. A., Burns, J. L., Zuccarino-Catania, G. 2019; 17 (3): 203–10
Abstract
The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.
View details for PubMedID 30865919